Hartmann, C., & Deimling, A. v. (2013). Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations. Clinical cancer research, 19(18), . https://doi.org/10.1158/1078-0432.CCR-13-0017
Chicago Style (17th ed.) CitationHartmann, Christian, and Andreas von Deimling. "Long-term Survival in Primary Glioblastoma with Versus Without Isocitrate Dehydrogenase Mutations." Clinical Cancer Research 19, no. 18 (2013). https://doi.org/10.1158/1078-0432.CCR-13-0017.
MLA (9th ed.) CitationHartmann, Christian, and Andreas von Deimling. "Long-term Survival in Primary Glioblastoma with Versus Without Isocitrate Dehydrogenase Mutations." Clinical Cancer Research, vol. 19, no. 18, 2013, https://doi.org/10.1158/1078-0432.CCR-13-0017.
Warning: These citations may not always be 100% accurate.